YaoGeJu

Company directoryChina company filings

Suzhou Dawnrays Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name Suzhou Dawnrays Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 43 active records with this name as holder; 37 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

54 acceptance records as first applicant, grouped into 31 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Ceftazidime for Injection 2 records · Latest accepted 2026/08/07

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601508Supplement2026/08/07Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2250663Supplement2022/10/25Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Sacubitril Valsartan Sodium Tablets 6 records · Latest accepted 2026/06/26

Supplement · 3Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601204Supplement2026/06/26Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2601203Supplement2026/06/26Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2601202Supplement2026/06/26Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHS2402552Generic2024/08/09Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHS2402550Generic2024/08/09Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHS2402547Generic2024/08/09Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Ceftazidime And Avibactam Sodium For Injection 1 records · Latest accepted 2026/06/04

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601307Generic2026/06/04Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Tedizolid Phosphate For Injection 1 records · Latest accepted 2025/12/02

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504128Generic2025/12/02Suzhou Dawnrays Pharmaceutical Co., Ltd.; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
Crisaborole Ointment 1 records · Latest accepted 2025/09/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503518Generic2025/09/25Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Ganirelix Injection 1 records · Latest accepted 2025/02/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500604Generic2025/02/07Suzhou Dawnrays Pharmaceutical Co., Ltd.; Amphastar Nanjing Pharmaceuticals Inc.CDE ↗
Rosuvastatin Calcium Tablets 3 records · Latest accepted 2024/12/31

Supplement · 2Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402240Supplement2024/12/31Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2400010Supplement2024/01/03Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHS2200803Generic2022/05/28Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Telmisartan And Amlodipine Tablets 1 records · Latest accepted 2024/10/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403350Generic2024/10/10Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
苯磺酸左氨氯地平片 · No verified English name 1 records · Latest accepted 2024/09/27

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450504Supplement2024/09/27Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Trelagliptin Succinate Tablets 2 records · Latest accepted 2024/09/09

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402964Generic2024/09/09Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHS2402963Generic2024/09/09Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Rivaroxaban Tablets 3 records · Latest accepted 2024/06/12

Supplement · 2Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400802Supplement2024/06/12Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2400801Supplement2024/06/12Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHS2101588Generic2021/08/16Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
头孢克肟片 · No verified English name 2 records · Latest accepted 2024/01/24

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450064Supplement2024/01/24Suzhou Dawnrays Pharmaceutical Co., Ltd.; Ncpc Hebei Huamin Pharmaceutical Co. Ltd.CDE ↗
CYHB2350173Supplement2023/02/14Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Atorvastatin Calcium Tablets 3 records · Latest accepted 2023/09/12

Supplement · 2Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302056Supplement2023/09/12Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2302055Supplement2023/09/12Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHS2102180Generic2021/12/11Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Cefazolin Sodium for Injection 1 records · Latest accepted 2023/07/06

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350531Supplement2023/07/06Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Cefoxitin Sodium for Injection 1 records · Latest accepted 2023/06/07

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350475Supplement2023/06/07Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Cefotaxime Sodium For Injection 2 records · Latest accepted 2023/05/24

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350455Supplement2023/05/24Suzhou Dawnrays Pharmaceutical Co., Ltd.; Ncpc Hebei Huamin Pharmaceutical Co. Ltd.CDE ↗
CYHB2350454Supplement2023/05/24Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Cefuroxime Sodium for Injection 2 records · Latest accepted 2023/04/19

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350357Supplement2023/04/19Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2350356Supplement2023/04/19Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Cefminox Sodium for Injection 1 records · Latest accepted 2023/03/23

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350283Supplement2023/03/23Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Cefprozil Tablets 2 records · Latest accepted 2023/01/05

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2300016Supplement2023/01/05Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2140002Supplement2021/01/09Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Cefoperazone Sodium and Sulbactam Sodium for Injection 3 records · Latest accepted 2023/01/04

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2340002Supplement2023/01/04Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2340001Supplement2023/01/03Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2150658Supplement2021/06/10Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Telmisartan Tablets 1 records · Latest accepted 2022/09/14

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250583Supplement2022/09/14Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Cefmetazole Sodium for Injection 2 records · Latest accepted 2022/05/25

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250287Supplement2022/05/25Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2250286Supplement2022/05/25Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Ceftriaxone Sodium for Injection 1 records · Latest accepted 2022/03/09

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250159Supplement2022/03/09Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Azithromycin for Suspension 1 records · Latest accepted 2021/11/25

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2151025Supplement2021/11/25Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Amlodipine Besylate and Atorvastatin Calcium Tablets 1 records · Latest accepted 2021/10/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101834Generic2021/10/11Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
注射用头孢哌酮钠舒巴坦钠(2:1) · No verified English name 2 records · Latest accepted 2021/07/24

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150747Supplement2021/07/24Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2150746Supplement2021/07/24Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
注射用头孢哌酮钠他唑巴坦钠(4:1) · No verified English name 2 records · Latest accepted 2021/07/12

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2101550Supplement2021/07/12Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
CYHB2101549Supplement2021/07/12Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Tenofovir alafenamide Fumarate Tablets 1 records · Latest accepted 2021/06/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101330Generic2021/06/25Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Losartan Potassium and Hydrochlorothiazide Tablets 1 records · Latest accepted 2021/05/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150596Supplement2021/05/18Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Cefoperazone Sodium For Injection 1 records · Latest accepted 2021/04/27

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150562Supplement2021/04/27Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Febuxostat Tablets 2 records · Latest accepted 2021/04/15

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2101141Supplement2021/04/15Suzhou Dawnrays Pharmaceutical Co., Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2101140Supplement2021/04/15Suzhou Dawnrays Pharmaceutical Co., Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Ceftazidime for Injection CYHB2601508Supplement2026/08/07Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Ceftazidime And Avibactam Sodium For Injection CYHS2601307Generic2026/06/04Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Tedizolid Phosphate For Injection CYHS2504128Generic2025/12/02Suzhou Dawnrays Pharmaceutical Co., Ltd.; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
Crisaborole Ointment CYHS2503518Generic2025/09/25Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

43 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Ganirelix InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Amphastar Nanjing Pharmaceuticals Inc.国药准字H202660492026/09/22Generic approved under the new chemical-drug registration classificationCDE ↗
Trelagliptin Succinate TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202643812026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Trelagliptin Succinate TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202643802026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Telmisartan And Amlodipine TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202632202026/01/27Generic approved under the new chemical-drug registration classificationCDE ↗
Sacubitril Valsartan Sodium TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202557222025/10/14Generic approved under the new chemical-drug registration classificationCDE ↗
Sacubitril Valsartan Sodium TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202557232025/10/14Generic approved under the new chemical-drug registration classificationCDE ↗
Sacubitril Valsartan Sodium TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202557242025/10/14Generic approved under the new chemical-drug registration classificationCDE ↗
苯磺酸左氨氯地平片 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H201038142025/07/14Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Rivaroxaban TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202580402025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Rivaroxaban TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202580412025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Cefazolin Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200340802024/11/12Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Atorvastatin Calcium TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202472752024/11/07Generic approved under the new chemical-drug registration classificationCDE ↗
Atorvastatin Calcium TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202472762024/11/07Generic approved under the new chemical-drug registration classificationCDE ↗
头孢克肟片 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200520762024/10/30Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Rosuvastatin Calcium TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202472002024/09/02Generic approved under the new chemical-drug registration classificationCDE ↗
Cefotaxime Sodium For InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200130592024/08/01Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200237012024/08/01Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoxitin Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200589852024/07/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefminox Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200655962024/06/21Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefuroxime Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200590712024/05/08Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefuroxime Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200590732024/05/08Drug that passed quality-and-efficacy consistency evaluationCDE ↗
头孢克肟片 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202470442024/03/19Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ceftazidime for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200232712024/02/06Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Rosuvastatin Calcium TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202345982023/12/05Generic approved under the new chemical-drug registration classificationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200590902023/11/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200590882023/11/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefmetazole Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H201634112023/10/27Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefmetazole Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H201634122023/10/27Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Telmisartan TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200611852023/08/17Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ceftriaxone Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200130582023/08/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Atorvastatin Calcium TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202337852023/06/27Generic approved under the new chemical-drug registration classificationCDE ↗
Tenofovir alafenamide Fumarate TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202336882023/06/07Generic approved under the new chemical-drug registration classificationCDE ↗
Amlodipine Besylate and Atorvastatin Calcium TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202334092023/04/04Not stated by sourceCDE ↗
Rivaroxaban TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202334022023/04/04Generic approved under the new chemical-drug registration classificationCDE ↗
Azithromycin for SuspensionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200581532022/12/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoperazone Sodium For InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H109830222022/11/21Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200130552022/09/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefprozil TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H201037922022/03/30Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Losartan Potassium and Hydrochlorothiazide TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200830092022/03/15Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tenofovir Disoproxil Fumarate TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H202139972021/12/31Generic approved under the new chemical-drug registration classificationCDE ↗
Telmisartan TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200701492021/10/27Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Amlodipine Besylate TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200310872021/08/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Clarithromycin TabletsSuzhou Dawnrays Pharmaceutical Co., Ltd.Suzhou Dawnrays Pharmaceutical Co., Ltd.国药准字H200568952021/07/22Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

37 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
利伐沙班 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20210000623A2023/04/13CDE ↗
富马酸丙酚替诺福韦 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20210000424A2023/06/15CDE ↗
头孢西丁钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190008279A2023/03/24CDE ↗
兰索拉唑 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190008223A—CDE ↗
头孢泊肟酯 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190008075A2025/06/13CDE ↗
盐酸伐昔洛韦 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190008064A2025/07/18CDE ↗
硫普罗宁 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190008063A2025/07/10CDE ↗
头孢他啶 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190007969A2025/06/26CDE ↗
甲氯噻嗪 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190007391A—CDE ↗
头孢他啶/碳酸钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190007334A2026/05/20CDE ↗
苯磺酸左氨氯地平 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190007139A2023/03/24CDE ↗
头孢替唑钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190006906A—CDE ↗
普卢利沙星 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190006722A—CDE ↗
盐酸贝那普利 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190006578A2026/03/21CDE ↗
头孢米诺钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190006527A—CDE ↗
头孢丙烯 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190006518A2026/06/11CDE ↗
头孢克肟 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190005228A2025/06/28CDE ↗
他唑巴坦钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190005082A2025/07/18CDE ↗
硫酸头孢匹罗 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190005078A2025/06/13CDE ↗
盐酸头孢吡肟 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190005074A2025/07/18CDE ↗
替米沙坦 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190005056A2025/07/18CDE ↗
盐酸左西替利嗪 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190005049A2025/06/28CDE ↗
头孢尼西钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190005048A2025/06/13CDE ↗
头孢特仑新戊酯 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190005047A2025/07/29CDE ↗
氯沙坦钾 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190005042A2025/04/17CDE ↗
头孢呋辛钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190004102A2025/06/28CDE ↗
盐酸西替利嗪 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190004086A2025/07/24CDE ↗
恩替卡韦 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190004082A2025/06/28CDE ↗
苯磺酸氨氯地平 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190004080A2025/06/28CDE ↗
头孢噻肟钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190003979A2025/07/18CDE ↗
乳酸司帕沙星 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190003965A2025/06/28CDE ↗
头孢曲松钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190003964A2025/07/04CDE ↗
头孢哌酮钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190003963A2025/10/22CDE ↗
枸橼酸铋钾 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190003962A2025/06/28CDE ↗
舒巴坦钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190003960A2025/05/31CDE ↗
富马酸替诺福韦二吡呋酯 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20190000384A2026/08/06CDE ↗
艾司奥美拉唑钠 · No verified English nameSuzhou Dawnrays Pharmaceutical Co., Ltd.Y20170000522A2024/12/20CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

3 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Rosuvastatin Calcium Tablets CYHB2501611Supplement2025/08/12SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Rosuvastatin Calcium Tablets CYHB2402223Supplement2024/12/26SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗
Rosuvastatin Calcium Tablets CYHB2402222Supplement2024/12/26SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Suzhou Dawnrays Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.